[Certain problems with limits of immunity against measles, mumps and rubella].
Strategic goals and schemes of immunization against measles, mumps and rubella in European countries with special attention for positive and negative sides of immunization against rubella and control of congenital rubella were described. Vaccines against mumps with strain Urabe AM9 were withdrawn in September 1992 in Great Britain. Decision was caused by increasing of complications after vaccination to 1 for 4000 doses of vaccine. (Former 1:4,000,000). Only mumps vaccine with strain Jeryl Lynn is there accepted. Including of vaccination against mumps to the calendar of vaccination in Poland was advised, when vaccine MMR with Jeryl Lynn mumps vaccine strain would be available. Monitoring of immunization of women against rubella would be necessary after above mentioned change in calendar of vaccinations.
Magdzik
W
W
Zakład Epidemiologii Państwowego Zakładu Higieny, Warszawie.
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations; D005060:Europe; D005260:Female; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D008297:Male; D008457:Measles / Q000517:prevention & control*; D008458:Measles Vaccine / Q000008:administration & dosage* / Q000009:adverse effects; D022542:Measles-Mumps-Rubella Vaccine; D008991:Monitoring, Physiologic; D009107:Mumps / Q000517:prevention & control*; D009108:Mumps Vaccine / Q000008:administration & dosage* / Q000009:adverse effects; D011044:Poland; D012409:Rubella / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000008:administration & dosage* / Q000009:adverse effects
D004338:Drug Combinations; D008458:Measles Vaccine; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine
Wybrane problemy z zakresu uodpornienia przeciw odrze, śwince i rózyczce.